Search
P-glycoprotein 1 (PGY1, multidrug resistance protein 1, MDR1, gp170, ATP-binding cassette subfamily B member 1, ABCB1)
Function:
- energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells
- P-glycoprotein 1 helps eliminate drugs by pumping them OUT of cells, back into the gut, bile, & urine for excretion
- substrates
- colchicine
- cyclosporin
- digoxin
- diltiazem
- etoposide
- glucocorticoids
- mefloquine
- nicardipine
- paclitaxel
- verapamil
- vinblastine
- vincristine
- vindesine
Structure:
- belongs to the ABC transporter family, multidrug resistance exporter (TC 3.A.1.201) subfamily
- contains 2 ABC transmembrane type-1 domains
- contains 2 ABC transporter domains
Compartment: membrane
Expression:
- expressed in liver, kidney, small intestine & brain
- inducers: St John's wort
- inhibitors:
- amiodarone
- clarithromycin
- cyclosporin
- diltiazem
- erythromycin
- indinavir
- itraconazole
- ketoconazole
- nicardipine
- ritonavir
- verapamil
Polymorphism:
- genetic variation in ABCB1 may play a role in patients who do not respond to drug treatment
- polymorphisms in ABCB1 may predispose to neuropsychiatric adverse effects of mefloquine [3]
Pathology:
- tumor cells may up-relate P-glycoprotein 1 as a mechanism for development of resistance to antineoplastic agents
Related
ABCB1 gene mutation
General
ATP-binding cassette sub-family B (ABC transporter-B, ABCB)
P-glycoprotein (gp170) or multidrug-resistance glycoprotein
Properties
SIZE: MW = 141 kD
entity length = 1280 aa
COMPARTMENT: cellular membrane
MOTIF: cytoplasmic domain {1-51}
transmembrane domain {52-72}
exoplasmic loop {73-119}
N-glycosylation site {N91}
N-glycosylation site {N94}
N-glycosylation site {N99}
transmembrane domain {120-140}
cytoplasmic loop {141-188}
transmembrane domain {189-209}
exoplasmic loop {210-215}
transmembrane domain {216-236}
cytoplasmic loop {237-296}
transmembrane domain {297-317}
exoplasmic loop {318-325}
transmembrane domain {326-346}
cytoplasmic loop {347-710}
MOTIF: ABC TRANSPORTER 1 {392-628}
ATP-binding site
NAME: ATP-binding site
SITE: 427-434
transmembrane domain {711-731}
exoplasmic loop {732-756}
transmembrane domain {757-777}
cytoplasmic loop {778-832}
transmembrane domain {833-853}
exoplasmic loop {854-853}
transmembrane domain {854-874}
cytoplasmic loop {875-936}
transmembrane domain {937-957}
exoplasmic loop {958-973}
transmembrane domain {974-994}
cytoplasmic domain {995-1280}
MOTIF: ABC TRANSPORTER 2 {1035-1273}
ATP-binding site
NAME: ATP-binding site
SITE: 1070-1077
SUBSTRATE: colchicine
CYLOSPORIN
digoxin
diltiazem
etoposide
glucocorticoid*
nicardipine
paclitaxel
verapamil
vinblastine
vincristine
VINDESINE
INDUCERS: Hypericum perforatum
INHIBITORS: amiodarone
clarithromycin
cyclosporin A
diltiazem
erythromycin
indinavir
itraconazole
ketoconazole
nicardipine
ritonavir
verapamil
Database Correlations
OMIM 171050
UniProt P08183
Entrez Gene 5243
References
- UniProt :accession P08183
- Entrez Gene :accession 5243
- Aarnoudse ALHJ et al,
MDR1 gene polymorphisms are associated with neuropsychiatric
adverse effects of mefloquine.
Clin Pharmacol Ther 2006, 80:367
PMID: 17015054
- Atlas of genetics & cytogenetics in oncology & haematology
http://atlasgeneticsoncology.org/genes/PGY1ID105.html
- NIEHS-SNPs
http://egp.gs.washington.edu/data/abcb1/
- SHMPD; The Singapore human mutation and polymorphism database
http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=ABCB1
- Wikipedia; Note: P-glycoprotein entry
http://en.wikipedia.org/wiki/P-glycoprotein